Literature DB >> 6493852

Effects of dichloroacetate on pyruvate metabolism in rat brain in vivo.

Y Kuroda, K Toshima, T Watanabe, H Kobashi, M Ito, E Takeda, M Miyao.   

Abstract

The effects of dichloroacetate (DCA) on the activity of the pyruvate dehydrogenase (PDH) complex and associated changes in the lactate and glucose levels in rat brain were investigated in vivo. The average activities of the active form of the PDH complex in the brain, liver and muscle of starved rats were respectively 0.40 +/- 0.04, 0.07 +/- 0.04, and 0.17 +/- 0.11 mumol/min/g tissue, and amounted to 21, 11, and 16% of the total activity of the complex. Intraperitoneal injection of DCA (125 mg/kg) increased the percentage of the active form of the PDH complex in the brain, liver, and muscle to 107, 40, and 84%, respectively. DCA significantly lowered the lactate and glucose concentrations of the brain and blood. A lower dose of DCA (12.5 mg/kg) also caused significant increase in activity of the PDH complex in the brain, but did not significantly change the lactate or glucose concentration of the brain. These results suggest that DCA crosses the blood-brain barrier reasonably well.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6493852     DOI: 10.1203/00006450-198410000-00005

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

1.  Treatment of chronic congenital lactic acidosis by oral administration of dichloroacetate.

Authors:  Y Kuroda; M Ito; K Toshima; E Takeda; E Naito; T J Hwang; T Hashimoto; M Miyao; M Masuda; K Yamashita
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  Effects of chlorinated acetates on the glutathione metabolism and on glycolysis of cultured astrocytes.

Authors:  Maike M Schmidt; Astrid Rohwedder; Ralf Dringen
Journal:  Neurotox Res       Date:  2010-07-14       Impact factor: 3.911

3.  Dichloroacetate increases glucose use and decreases lactate in developing rat brain.

Authors:  A L Miller; J P Hatch; T J Prihoda
Journal:  Metab Brain Dis       Date:  1990-12       Impact factor: 3.584

4.  CoA-dependent activation of mitochondrial acyl carrier protein links four neurodegenerative diseases.

Authors:  Roald A Lambrechts; Hein Schepers; Yi Yu; Marianne van der Zwaag; Kaija J Autio; Marcel A Vieira-Lara; Barbara M Bakker; Marina A Tijssen; Susan J Hayflick; Nicola A Grzeschik; Ody Cm Sibon
Journal:  EMBO Mol Med       Date:  2019-11-07       Impact factor: 12.137

5.  The orphan drug dichloroacetate reduces amyloid beta-peptide production whilst promoting non-amyloidogenic proteolysis of the amyloid precursor protein.

Authors:  Edward T Parkin; Jessica E Hammond; Lauren Owens; Matthew D Hodges
Journal:  PLoS One       Date:  2022-01-13       Impact factor: 3.240

6.  Antitumor activity of dichloroacetate on C6 glioma cell: in vitro and in vivo evaluation.

Authors:  Yu Duan; Xin Zhao; Wei Ren; Xin Wang; Ke-Fu Yu; Dan Li; Xuan Zhang; Qiang Zhang
Journal:  Onco Targets Ther       Date:  2013-03-14       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.